The Institute of Medical Science, The University Of Tokyo

NEWS

2024.02.01

A research article on cancer immunotherapy as a result of the Co-Center Project between our lab and the group of Peter D. Katsikis at Erasmus University Medical Center in the Netherlands has been published in J Immunol.

 

TLR9 plus STING Agonist Adjuvant Combination Induces Potent Neopeptide T Cell Immunity and Improves Immune Checkpoint Blockade Efficacy in a Tumor Model

Castro Eiro MD, Hioki K, Li L, Wilmsen MEP, Kiernan CH, Brouwers-Haspels I, van Meurs M, Zhao M, de Wit H, Grashof DGB, van de Werken HJG, Mueller YM, Schliehe C, Temizoz B, Kobiyama K, Ishii KJ, Katsikis PD.

J Immunol. 2024 Feb 1;212(3):455-465. doi: 10.4049/jimmunol.2300038.

Ishii's Laboratory

Division of Vaccine Science
The Institute of Medical Science, The University of Tokyo
4-6-1 Shirokanedai Minato-ku

vaccine★ims.u-tokyo.ac.jp※Please change ★ to @ and send